Trials / Completed
CompletedNCT04720040
The Efficacy and Safety of tDCS in Patients With Mild to Moderate Major Depressive Disorder
Using YMS-201B in Patients With Mild to Moderate Major Depressive Disorder To Evaluate Efficacy and Safety for the Effect of Improving Depressive Symptoms Open, Single-group, Multicenter Confirmatory Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Ybrain Inc. · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated the effectiveness and safety of improving depressive symptoms by applying tDCS for 6 weeks to patients with mild to moderate depression.
Detailed description
Patients received tDCS for 30 minutes with an intensity of 1.5 to 2 mA. tDCS was applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC) 5\~7 times a week and they were evaluated every 2weeks through questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mind STIM | transcranial Direct Current Stimulation (tDCS) 2mA for 30 min; 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC) |
Timeline
- Start date
- 2019-12-23
- Primary completion
- 2020-08-31
- Completion
- 2020-10-15
- First posted
- 2021-01-22
- Last updated
- 2021-01-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04720040. Inclusion in this directory is not an endorsement.